Nanomaterials for targeted drug delivery for immunotherapy of digestive tract tumors

Area of Science:

• Oncology
• Materials Science
• Nanotechnology

Background:

• Digestive tract tumors, particularly gastric and colorectal cancers, exhibit high global incidence and mortality rates.
• Nanoparticles (NPs) offer advantages in drug delivery for gastrointestinal tumors, including efficient loading, safety, and targeting.
• Current clinical application of NPs is hindered by high costs, limited clinical trials, and lengthy approval processes.

Purpose of the Study:

• To review immunotherapeutic nanomaterial drugs for gastrointestinal tumors.
• To summarize the current research and development status in this field.
• To provide theoretical references for novel drug development and clinical research advancement.

Main Methods:

• Categorization of nanomaterial drugs into organic, inorganic, and hybrid types.
• Discussion of the advantages associated with each nanomaterial category.
• Analysis of the current research and development landscape for nanomaterials in gastrointestinal oncology.

Main Results:

• Identified three main categories of immunotherapeutic nanomaterials: organic, inorganic, and hybrid.
• Detailed the unique advantages of each nanomaterial type for gastrointestinal tumor treatment.
• Highlighted the existing challenges and future directions for clinical translation.

Conclusions:

• Nanomaterials hold significant potential for advancing gastrointestinal tumor therapy.
• Further research and clinical trials are necessary to overcome barriers to practical application.
• This review provides a foundation for developing next-generation nanomaterial-based cancer treatments.